AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Assura PLC

Regulatory Filings Jul 24, 2013

4924_10-k_2013-07-24_340bbce4-3cc6-408b-845e-9a8b1fca3f09.html

Regulatory Filings

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0357K

Assura Group Limited

24 July 2013

24 July 2013

For immediate release

Assura Group Limited

Annual Information Update

In accordance with Prospectus Rule 5.2, Assura Group Limited (the "Company") sets out below a summary of the information which has been published or made available to the public during the period 21 July 2012 to 20 July 2013.

This annual information update is required by and is being made pursuant to Article 10 of the Prospectus Directive (Prospective Rule 5.2) and not for any other purpose. Information is referred to in this update rather than included in full. The information referred to was up to date at the time it was published; however, some information may now be out of date.

1.         Regulatory Announcements

The following UK regulatory announcements have been issued through RNS, a Regulatory News Service. They can be viewed or downloaded from the London Stock Exchange website (www.londonstockexchange.com) in the Market News section, searching under the Company's code AGR.

Date Announcement
15 August 2012 Interim Management Statement
31 August 2012 Annual Information Update
11 September 2012 Result of AGM
18 September 2012 Appointment of Finance Director
21 September 2012 Holding in Company - Laxey Partners Limited
25 September 2012 Assura Group Transfer of Shares
27 September 2012 Appointment of joint corporate broker
28 September 2012 Confirmation of Quarterly Interim Dividend
13 November 2012 Announcement of half year results date
28 November 2012 Assura Group Limited Interim Results 2012
29 November 2012 Director Shareholding Announcement-Replacement
10 December 2012 Director/PDMR Shareholding
21 December 2012 Confirmation of Quarterly Interim Dividend
08 January 2013 Sale of Former Head Office Building
28 January 2013 Notice of Extraordinary General Meeting
29 January 2013 Notification of Grant of Share Award to PDMR
31 January 2013 Interim Management Statement
15 February 2013 Results of EGM
13 March 2013 Director/PDMR Shareholding
02 April 2013 Confirmation of REIT status
17 May 2013 Statement re Possible Offer
17 May 2013 Announcement re unsolicited approach
20 May 2013 Form 8.3 - MedicX Fund Limited
20 May 2013 Form 8.3 - Assura Group Limited
20 May 2013 Form 8.3 - Assura Group Limited
20 May 2013 Form 8.5 (EPT/NON-RI)
20 May 2013 Form 8.5 (EPT/NON-RI)
20 May 2013 Form 8.5 (EPT/RI)
20 May 2013 Form 8.3 - Assura Group
20 May 2013 Possible offer update and Rule 2.10 disclosure
20 May 2013 Form 8.3 - Assura Group Ltd
20 May 2013 Form 8.3 - MedicX Fund Limited
20 May 2013 Form 8.3 - [Assura Group Limited]
20 May 2013 Form 8.3 - Assura Group Ltd
21 May 2013 Form 8.3 - Assura Group Limited
21 May 2013 Form 8.5 (EPT/NON-RI)
21 May 2013 Form 8.5 (EPT/RI)
21 May 2013 Form 8.5 (EPT/NON-RI)
22 May 2013 Form 8.5 (EPT/NON-RI)
22 May 2013 Form 8.3 - Assura Group Limited
22 May 2013 Form 8.5 (EPT/NON-RI)- Replacement
22 May 2013 Form 8.3 - Assura Group
22 May 2013 Form 8.3 - Assura Group Ltd
22 May 2013 Form 8.5 (EPT/RI)
22 May 2013 Form 8.3 - Assura Group Limited
22 May 2013 Form 8.5 (EPT/NON-RI)
23 May 2013 Form 8.5 (EPT/NON-RI)
23 May 2013 Form 8.5 (EPT/NON-RI)
23 May 2013 Form 8.5 (EPT/RI)
23 May 2013 Form 8.3 - Assura Group Limited Replacement
23 May 2013 Form 8.3 - Medicx Fund Ltd
23 May 2013 Form 8.5 (EPT/NON-RI)
24 May 2013 Form 8.5 (EPT/NON-RI)
24 May 2013 Form 8.5 (EPT/NON-RI)
24 May 2013 Form 8.5 (EPT/RI)
28 May 2013 Form 8.5 (EPT/NON-RI)
28 May 2013 Form 8.5 (EPT/NON-RI)
28 May 2013 Form 8.5 (EPT/RI)
28 May 2013 Offer Update
28 May 2013 Form 8.3 - Assura Group Ltd
28 May 2013 Rejection of MedicX Proposal
28 May 2013 Unaudited Preliminary Results to 31 March 2013
29 May 2013 Form 8.5 (EPT/NON-RI)
29 May 2013 Form 8.5 (EPT/NON-RI)
29 May 2013 Form 8.5 (EPT/NON-RI)
29 May 2013 Form 8.5 (EPT/RI)
17 June 2013 Confirmation of Quarterly Interim Dividend

2.         Documents filed at Companies House

Date Announcement
10 August 2012 Change of Address
11 January 2013 Director Appointed Mr Jonathan Stewart Murphy
14 January 2013 Group of Companies' Accounts made up to 31/03/12
22 January 2013 Appointment Terminated, Secretary Carolyn Jones
22 January 2013 Secretary Appointed, Jonathan Murphy
12 March 2013 Altn Constitutional Doc 15/02/2013

3.         Annual and interim reports

The Company's annual report for the year ended 31 March 2012, interim report for the six months to 30 September 2012 and annual report for the year ending 31 March 2013 can be downloaded from the Company's website at http://www.assuragroup.co.uk/investor-relations/reports-presentations/2013.aspx.

A copy of this annual information update and all documents referred to in it can be obtained from the Company's branch address:

Assura Group Limited

The Brew House

Greenalls Avenue

Warrington

Cheshire

WA4 6HL

For further information, please contact:

Jonathan Murphy

Company Secretary

Assura Group Limited

Tel: 01925 420660

Notes to Editors

Assura Group is a long-term investor in and developer of primary care property. The company, headquartered in Warrington and listed on the London Stock Exchange, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2013, Assura Group's property portfolio was valued at £569 million.

Further information is available at www.assuragroup.co.uk

This information is provided by RNS

The company news service from the London Stock Exchange

END

AIUUSUKROOABURR

Talk to a Data Expert

Have a question? We'll get back to you promptly.